You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Non-Small Lung Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy

Not yet recruiting
  • Non-small Cell Lung Cancer Metastatic
    • (no location specified)
    Sep 13, 2023

    Acute Side Effects In Stage III NSCLC With Definitive CRT

    Completed
    • Non-small Cell Lung Cancer Stage III
      • Ankara, Turkey
        Ankara University Medicine School Radiation Oncology
      Aug 22, 2023

      Lung Cancer, Lung Cancer, Small Cell Trial in Gaziantep (Pulmonary Rehabilitation)

      Not yet recruiting
      • Lung Cancer
      • Lung Cancer, Small Cell
      • Pulmonary Rehabilitation
      • Gaziantep, Turkey
        Hasan Kalyoncu Univercity
      Apr 1, 2022

      Double-dose Furmonertinib in Treatment of Slow

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • (no location specified)
      Oct 31, 2023

      NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Non-small Cell Lung Cancer Stage IV
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Sep 21, 2022

      Specific Protein Overexpression in Adult Non-Small Cell Lung

      Not yet recruiting
      • Non Small Cell Lung Cancer
        • (no location specified)
        Sep 29, 2023

        NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +2 more
        • Nintedanib, gefitinib, erlotinib, afatinib
        • (no location specified)
        Oct 2, 2023

        NSCLC Trial in Shanghai

        Not yet recruiting
        • Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Jul 20, 2023

          Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

          Not yet recruiting
          • Stage II-IIIB(N2) Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Oct 26, 2023

          NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

          Recruiting
          • Non-small Cell Lung Cancer
          • +3 more
          • Yangzhou, Jiangsu, China
            People's hospital of northern jiangsu
          Sep 26, 2023

          NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Tirelizumab；Chemotherapy monotherapy
          • (no location specified)
          Jul 27, 2023

          Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

          Recruiting
          • Non Small Cell Lung Cancer
          • quaratusugene ozeplasmid
          • +3 more
          • Tampa, Florida
          • +2 more
          Sep 12, 2022

          Identify Resected Non-small-cell Lung Cancer With High Risk of

          Recruiting
          • Non-small Cell Lung Cancer Stage IIIA
          • Resected non small cell lung cancer
          • Toulouse, France
            Julien MAZIERES
          Feb 8, 2023

          NSCLC Trial (SGN-B6A, docetaxel)

          Not yet recruiting
          • Carcinoma, Non-Small-Cell Lung
          • (no location specified)
          Aug 21, 2023

          NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • (no location specified)
          Sep 6, 2023

          NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Iowa City, Iowa
            University of Iowa
          Oct 10, 2023

          Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

          Not yet recruiting
          • Metastatic Lung Non-Small Cell Carcinoma
          • +2 more
          • Cetuximab
          • +2 more
          • Sacramento, California
            University of California Davis Comprehensive Cancer Center
          Oct 2, 2023

          Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

          Recruiting
          • Non Small Cell Lung Cancer
          • +2 more
          • Port Saint Lucie, Florida
          • +1 more
          Aug 11, 2023

          NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

          Not yet recruiting
          • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
          • (no location specified)
          Aug 27, 2023

          TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

          Not yet recruiting
          • Lung Cancer, Non-small Cell
          • Small Cell Lung Cancer
            • (no location specified)
            Nov 16, 2022

            Integrative Multi-Omics Testing for Immunotherapy Response in

            Recruiting
            • Lung Cancer
              • Guangzhou, Guangdong, China
                Nanfang hospital
              Jun 29, 2023

              NSCLC Trial in Guangzhou (BL-M07D1)

              Not yet recruiting
              • Non-small Cell Lung Cancer
              • Guangzhou, Guangdong, China
                Sun Yat-sen University Cancer Center
              Nov 1, 2023

              Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

              Recruiting
              • Untreated Advanced Non-small Cell Lung Cancer
              • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
              • Fuzhou, Fujian, China
                Fujian Cancer Hospital
              Nov 13, 2023

              Metabolic Response to Food in Advanced Lung Cancer

              Not yet recruiting
              • Carcinoma, Non-Small-Cell Lung
              • Weight loss (%)
              • (no location specified)
              Jun 30, 2023

              Extensive Stage Small Cell Lung Cancer

              Not yet recruiting
              • Extensive-stage Small-cell Lung Cancer
                • Changsha, Hunan, China
                  Hunan Cancer hospital
                Aug 6, 2023